Search Results - "Fabregas, Jesus C."

Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors by Aduse-Poku, Livingstone, Karanth, Shama D, Wheeler, Meghann, Yang, Danting, Washington, Caretia, Hong, Young-Rock, Manini, Todd M, Fabregas, Jesus C, Cheng, Ting-Yuan David, Braithwaite, Dejana

“…: The importance of body composition on cancer outcomes is of great clinical interest. Measures of body composition that differentiate fat mass from skeletal…”
Get full text

Clinical Updates for Colon Cancer Care in 2022 by Fabregas, Jesus C., Ramnaraign, Brian, George, Thomas J.

“…Colon cancer needs better screening and treatment options. Its incidence in the young population is rising. Recent changes in guidelines recommend beginning…”
Get full text

Addendum: Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis by Kucharczyk, Michael Jonathan, Bang, Andrew, Tjong, Michael C., Papatheodorou, Stefania, Fabregas, Jesus C.

Get full text

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis by Kucharczyk, Michael Jonathan, Bang, Andrew, Tjong, Michael C., Papatheodoru, Stefania, Fabregas, Jesus C.

“…INTRODUCTIONThe total mesorectal excision (TME) significantly improved rectal cancer outcomes. Radiotherapy's benefit in T3N0 rectal cancer patients managed…”
Get full text

The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma by Khushman, Moh’d, Prodduturvar, Pranitha, Mneimneh, Wadad, Dal Zotto, Valeria, Akbar, Shalla, Grimm, Leander, Rider, Paul, Hunter, John, Alkharabsheh, Omar, Patel, Girijesh Kumar, Fabregas, Jesus C., Singh, Ajay P.

“…INTRODUCTIONExosomes have pivotal roles in cancer development. The impact of neoadjuvant concurrent chemoradiation (NCCR) on exosomal markers (CD63 and CD9)…”
Get full text

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma by Singhal, Ruchi, Rogers, Sherise C, Lee, Ji-Hyun, Ramnaraign, Brian, Sahin, Ilyas, Fabregas, Jesus C, Thomas, Ryan M, Hughes, Steven J, Nassour, Ibrahim, Hitchcock, Kathryn, Russell, Karen, Kayaleh, Omar, Turk, Anita, Zlotecki, Robert, DeRemer, David L, George, Thomas J

“…For patients with localized pancreatic cancer with minimal vascular involvement, optimal survivability requires a multidisciplinary approach of surgical…”
Get full text

Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma by Fabregas, Jesus C., Carter, Benjamin T., Lutzky, Jose, Robinson, William Russell, Brant, Jeannine M.

“…Background Black patients are diagnosed with melanoma at a later stage, as compared with their white counterparts. It is unknown if Medicaid expansion might…”
Get full text

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B‐cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort by Evens, Andrew M., Kanakry, Jennifer A., Sehn, Laurie H., Kritharis, Athena, Feldman, Tatyana, Kroll, Aimee, Gascoyne, Randy D., Abramson, Jeremy S., Petrich, Adam M., Hernandez‐Ilizaliturri, Francisco J., Al‐Mansour, Zeina, Adeimy, Camille, Hemminger, Jessica, Bartlett, Nancy L., Mato, Anthony, Caimi, Paolo F., Advani, Ranjana H., Klein, Andreas K., Nabhan, Chadi, Smith, Sonali M., Fabregas, Jesus C., Lossos, Izidore S., Press, Oliver W., Fenske, Timothy S., Friedberg, Jonathan W., Vose, Julie M., Blum, Kristie A.

“…Gray zone lymphoma (GZL) with features between classical Hodgkin lymphoma and diffuse large B‐cell lymphoma (DLBCL) is a recently recognized entity reported to…”
Get full text

Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial by Ramnaraign, Brian H, Lee, Ji-Hyun, Ali, Azka, Rogers, Sherise C, Fabregas, Jesus C, Thomas, Ryan M, Allegra, Carmen J, Sahin, Ilyas, DeRemer, David L, George, Thomas J, Chatzkel, Jonathan A

“…Immune checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance and the…”
Get full text

Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer by Fabregas, Jesus C., Riley, Kristen E., Brant, Jeannine M., George, Thomas J., Orav, E. John, Lam, Miranda B.

“…BackgroundPancreatic cancer disparities have been described. However, it is unknown if they contribute to a late diagnosis and survival of patients with…”
Get full text

Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors by Diaz, Claudia Marcela, Chiappori, Alberto, Aurisicchio, Luigi, Bagchi, Ansuman, Clark, Jason, Dubey, Sheri, Fridman, Arthur, Fabregas, Jesus C, Marshall, John, Scarselli, Elisa, La Monica, Nicola, Ciliberto, Gennaro, Montero, Alberto J

“…DNA electroporation has been demonstrated in preclinical models to be a promising strategy to improve cancer immunity, especially when combined with other…”
Get full text

Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma by Altshuler, Ellery, Riner, Andrea N, Herremans, Kelly M, George, Thomas J, Rogers, Sherise C, Paniccia, Alessandro, Hughes, Steven J, Fabregas, Jesus C, Nassour, Ibrahim

“…Pancreatic adenosquamous carcinoma (PASC) is a rare cancer that often presents with advanced disease and carries a grim prognosis. PASC is defined by the…”
Get full text

Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma by Lossos, Izidore S, Fabregas, Jesus C, Koru-Sengul, Tulay, Miao, Feng, Goodman, Deborah, Serafini, Aldo N, Hosein, Peter J, Stefanovic, Alexandra, Rosenblatt, Joseph D, Hoffman, James E

“…The best upfront therapy for patients with non-gastric extranodal marginal zone lymphomas (MZLs) is not defined. We assessed the safety and efficacy of…”
Get full text

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis by Ozer, Muhammet, Goksu, Suleyman Yasin, Lin, Rick Y, Ayasun, Ruveyda, Kahramangil, Doga, Rogers, Sherise C, Fabregas, Jesus C, Ramnaraign, Brian H, George, Thomas J, Feely, Michael, Cabrera, Roniel, Duarte, Sergio, Zarrinpar, Ali, Sahin, Ilyas

“…Advanced hepatocellular carcinoma (HCC) generally has a dismal prognosis. Bone metastases from HCC are infrequent, with a poorer prognosis. However, the…”
Get full text

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review by Altshuler, Ellery, Richhart, Raymond, Aryan, Mahmoud, King, William, Pan, Kelsey, Mathavan, Akash, Mathavan, Akshay, Rodriguez, Diana, Paudel, Bishal, Northern, Nathan, Ramnaraign, Brian, Sahin, Ilyas, Fabregas, Jesus C

“…Although up to one in five cases of hepatocellular carcinoma (HCC) occurs in patients without cirrhosis, there is scarce literature characterizing…”
Get full text

Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer by Fabregas, Jesus C, Loaiza-Bonilla, Arturo, Talebi, Toni N, Warsch, Sean, Fernandez, Gustavo, Raez, Luis E, Santos, Edgardo S

“…Concurrent chemoradiation is considered the standard-of-care for locally advanced head and neck cancer of the hypopharynx, oropharynx and larynx, as well as…”
Get full text

Impact of social determinants of health on a late diagnosis and survival of patients with pancreatic cancer by Fabregas, Jesus C., Lam, Miranda

“…Abstract only e18530 Background: While disparities in pancreatic cancer (PC) are documented, it is unclear whether these inequities occur at the time of…”
Get full text

Conservative Management of Idiopathic Hemophagocytic Lymphohistiocytosis (HLH) Achieving Complete Remission by Fabregas, Jesus C, Carvajal, Guiset

“…Introduction Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by overwhelming activation of the immune system. The disease can affect…”
Get full text

Association between Medicaid expansion status and metastatic disease at diagnosis in patients with melanoma by Fabregas, Jesus C., Brant, Jeannine M.

“…Abstract only 7030 Background: The Affordable Care Act (ACA) expanded Medicaid coverage in 2010. It is unknown what impact the ACA expansion has had on a…”
Get full text

Impact of radiotherapy for local control in T3 N0 rectal cancer managed with total mesorectal excision: A systematic review and meta-analysis by Fabregas, Jesus C., Bang, Andrew, Tjong, Michael, Kucharczyk, Michael

“…Abstract only 3604 Background: Total mesorectal excision (TME) significantly improved rectal cancer outcomes. Radiotherapy (RT) is recommended for T3N0 rectal…”
Get full text